The economic burden of Ebola virus disease: a review and recommendations for analysis

References

• Centers for Disease Control and Prevention. Outbreaks Ebola (Ebola Virus Disease). 2023 https://www.cdc.gov/vhf/ebola/outbreaks/index-2018.html
   Google Scholar
• World Health Organization. Ebola haemorrhagic fever in Zaire, 1976. Bulletin of the World Health Organization. 1978;56:271–293.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Ebola (Ebola Virus Disease) | CDC. Ebola (Ebola Virus Disease). 2018. p. 1. https://www.cdc.gov/vhf/ebola/index.html.
   Google Scholar
• Weyer J, Grobbelaar A, Blumberg L. Ebola virus disease: history, epidemiology and outbreaks. Curr Infect Dis Rep. 2015;17(5)Current Medicine Group LLC:480. doi:10.1007/s11908-015-0480-y.
   PubMed Web of Science ®Google Scholar
• Wiwanitkit V. Ebola virus disease. J Chin Med Assoc. 2015;78(4):264. https://www.sciencedirect.com/science/article/pii/S1726490115000593.
   PubMed Web of Science ®Google Scholar
• Maxmen A. World’s second-deadliest ebola outbreak ends in democratic republic of the Congo. Nature. 2020; doi:10.1038/d41586-020-01950-0.
   Google Scholar
• Harris M, Boakye-Agyemang C. New Ebola outbreak detected in northwest Democratic Republic of the Congo; WHO surge team supporting the response. World Health Organization. 2020. https://www.who.int/news-room/detail/01-06-2020-new-ebola-outbreak-detected-in-northwest-democratic-republic-of-the-congo-who-surge-team-supporting-the-response
   Google Scholar
• Centers for Disease Control and Prevention. 2020 Democratic Republic of the Congo, Equateur Province (ongoing) | Democratic Republic of Congo | Outbreaks | Ebola (Ebola Virus Disease) | CDC. 2020. https://www.cdc.gov/vhf/ebola/outbreaks/drc/2020-june.html
   Google Scholar
• Measles: the never-ending fight against one of the world’s most contagious diseases - Democratic Republic of the Congo | ReliefWeb. 2023. https://reliefweb.int/report/democratic-republic-congo/measles-never-ending-fight-against-one-worlds-most-contagious-diseases
   Google Scholar
• Nachega JB, Mbala-Kingebeni P, Otshudiema J, et al. The colliding epidemics of COVID-19, ebola, and measles in the democratic republic of the Congo. Lancet Glob Health. 2020;8(8):e991–e992. doi:10.1016/S2214-109X(20)30281-3.
   PubMed Web of Science ®Google Scholar
• Judson S, Prescott J, Munster V. Understanding ebola virus transmission. Viruses. MDPI AG. 2015;7(2):511–521. doi:10.3390/v7020511.
   PubMed Web of Science ®Google Scholar
• World Health Organization. What we know about transmission of the ebola virus among humans. Media centre; news releases. 2014. p. 2014–2016. https://www.who.int/mediacentre/news/ebola/06-october-2014/en/
   Google Scholar
• Rewar S, Mirdha D. Transmission of ebola virus disease: an overview. Ann Glob Health. 2014;80(6):444–451. Elsevier USA doi:10.1016/j.aogh.2015.02.005.
   PubMed Web of Science ®Google Scholar
• Wilder-Smith A. COVID-19 in comparison with other emerging viral diseases: risk of geographic spread via travel. Trop Dis Travel Med Vaccines. 2021;7(1):3. doi:10.1186/s40794-020-00129-9.
   PubMedGoogle Scholar
• Tomori O, Kolawole MO. Ebola virus disease: current vaccine solutions. Curr Opin Immunol. 2021; 71:27–33. https://www.sciencedirect.com/science/article/pii/S0952791521000285.
   PubMed Web of Science ®Google Scholar
• Gire SK, Goba A, Andersen KG, et al. Genomic surveillance elucidates ebola virus origin and transmission during the 2014 outbreak. Science. 2014;345(6202):1369–1372. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431643/.
   PubMed Web of Science ®Google Scholar
• Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire ebola virus disease in Guinea. N Engl J Med. 2014;371(15):1418–1425. doi:10.1056/NEJMoa1404505.
   PubMed Web of Science ®Google Scholar
• Haque A, Hober D, Blondiaux J. Addressing therapeutic options for ebola virus infection in current and future outbreaks. Antimicrob Agents Chemother. 2015;59(10):5892–5902. doi:10.1128/AAC.01105-15.
   PubMed Web of Science ®Google Scholar
• Bartsch SM, Gorham K, Lee BY. The cost of an ebola case. Pathog Glob Health. 2015;109(1):4–9. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L603981462.
   PubMed Web of Science ®Google Scholar
• Bowles J, Hjort J, Melvin T, et al. Ebola, jobs and economic activity in Liberia. J Epidemiol Community Health. 2016;70(3):271–277. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L614446481. doi:10.1136/jech-2015-205959.
   PubMed Web of Science ®Google Scholar
• Da Costa S. The impact of the ebola crisis on mortality and welfare in Liberia. Health Econ. 2020;29(12):1517–1532. doi:10.1002/hec.4150.
   PubMed Web of Science ®Google Scholar
• Elmahdawy M, Elsisi GH, Carapinha J, et al. Ebola virus epidemic in west africa: global health economic challenges, lessons learned, and policy recommendations. Value Health Reg Issues. 2017;13:67–70. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L618232240. doi:10.1016/j.vhri.2017.08.003.
   PubMedGoogle Scholar
• Huber C, Finelli L, Stevens W. The economic and social burden of the 2014 ebola outbreak in west africa. J Infect Dis. 2018;218(suppl_5):S698–S704. https://academic.oup.com/jid/article-abstract/218/suppl_5/S698/5129071. doi:10.1093/infdis/jiy213.
   PubMed Web of Science ®Google Scholar
• Kirigia JM, P A, Masiye F, et al. Indirect costs associated with deaths from the ebola virus disease in west africa. Infect Dis Poverty. 2015;4(1):45. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L606662254. doi:10.1186/s40249-015-0079-4.
   PubMedGoogle Scholar
• Kirigia JM, Muthuri RNDK, Muthuri NG. The monetary value of human lives lost through ebola virus disease in the democratic republic of Congo in 2019. BMC Public Health. 2019;19(1):1218. doi:10.1186/s12889-019-7542-2.
   PubMed Web of Science ®Google Scholar
• Kum FV, Olayiwola S, Aloysius NM. The impact of ebola virus disease on government expenditure in Sierra Leone. In: Socio-cultural dimensions of emerging infectious diseases in Africa. Springer Nature Switzerland AG; 2019. p. 75–90. https://www.worldbank.org/en/topic/macroeconomics/publication/2014-2015-west-africa-ebola-crisis-impact-update
   Google Scholar
• Morrison IDL, Anderson BI, Brower AI, et al. Macroeconomic impact of ebola outbreaks in Sub-Saharan africa and potential mitigation of GDP loss with prophylactic ebola vaccination programs. PLOS ONE. 2023;18(4):e0283721. doi:10.1371/journal.pone.0283721.t001.
   PubMed Web of Science ®Google Scholar
• Olugasa BO, Oshinowo OY, Odigie EA. Preventive and social cost implications of ebola virus disease (EVD) outbreak on selected organizations in Lagos state, Nigeria. Pan Afr Med J. 2015;22(Supp 1):20–20. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L616010262. doi:10.11604/pamj.supp.2015.22.1.6673.
   PubMedGoogle Scholar
• Onyekuru NA, Ihemezie EJ, Ezea CP, et al. Impacts of ebola disease outbreak in west africa: implications for government and public health preparedness and lessons from COVID-19-NC-ND license. Sci Afr. 2023;19:e01513. (http://creativecommons.org/licenses/by-nc-nd/4.0/). doi:10.1016/j.sciaf.2022.e01513.
   PubMedGoogle Scholar
• Zacharowski K, Brodt HR, Wolf T. Medical treatment of an ebola-infected doctor - Ethics over costs? Lancet. 2015;385(9969):685–685. doi:10.1016/S0140-6736(15)60279-3.
   PubMed Web of Science ®Google Scholar
• Zeng W, Samaha H, Yao M, et al. The cost of public health interventions to respond to the 10th ebola outbreak in the democratic republic of the Congo. BMJ Glob Health. 2023; 8(10):e012660. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583089/. doi:10.1136/bmjgh-2023-012660.
   PubMed Web of Science ®Google Scholar
• Huo X, Shi G, Li X, et al. Knowledge and attitudes about ebola vaccine among the general population in Sierra Leone. Vaccine. 2016;34(15):1767–1772. doi:10.1016/j.vaccine.2016.02.046.
   PubMed Web of Science ®Google Scholar
• Kpanake L, Sorum PC, Mullet É. Willingness to get vaccinated against ebola: a mapping of guinean people positions. Hum Vaccin Immunother. 2018;14(10):2391–2396. doi:10.1080/21645515.2018.1480236.
   PubMed Web of Science ®Google Scholar
• Mudatsir M, Anwar S, Karunia Fajar J, et al. Willingness-to-pay for a hypothetical ebola vaccine in Indonesia: a cross-sectional study in Aceh. F1000Res. 2019;8:1441. doi:10.12688/f1000research.20144.1.
   PubMedGoogle Scholar
• Painter JE, von Fricken ME, Viana de O, et al. Willingness to pay for an ebola vaccine during the 2014–2016 ebola outbreak in west africa: results from a U.S. National sample. Hum Vaccin Immunother. 2018;14(7):1665–1671. doi:10.1080/21645515.2018.1423928.
   PubMed Web of Science ®Google Scholar
• Ughasoro MD, Esangbedo DO, Tagbo BN, et al. Acceptability and willingness-to-pay for a hypothetical ebola virus vaccine in Nigeria. PLoS Negl Trop Dis. 2015;9(6):e0003838. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L605059981. doi:10.1371/journal.pntd.0003838.
   PubMed Web of Science ®Google Scholar
• Obeng-Kusi M, Habila MA, Roe DJ, et al. Economic evaluation using dynamic transition modeling of ebola virus vaccination in lower-and-Middle-income countries. J Med Econ. 2021;24(sup1):1–13. doi:10.1080/13696998.2021.2002092.
   PubMed Web of Science ®Google Scholar
• Kellerborg K, Brouwer W, Van Baal P. Costs and benefits of early response in the ebola virus disease outbreak in Sierra Leone. Cost Eff Resour Alloc. 18(1):13. doi:10.1186/s12962-020-00207-x.
   PubMed Web of Science ®Google Scholar
• Abraham N, Jain A, Harrison D, et al. 70 A cost analysis of a county hospital emergency department’s ebola virus disease preparedness. Ann Emerg Med. 2015;66(4):S25. doi:10.1016/j.annemergmed.2015.07.102.
   PubMedGoogle Scholar
• Herstein JJ, Biddinger PD, Kraft CS, et al. Initial costs of ebola treatment centers in the United States. Emerg Infect Dis. 2016;22(2):350–352. doi:10.3201/eid2202.151431.
   PubMed Web of Science ®Google Scholar
• Herstein JJ, Le AB, McNulty LA, et al. Update on ebola treatment center costs and sustainability, United States, 2019. Emerg Infect Dis. 2020;26(5):1007–1009. doi:10.3201/eid2605.191245.
   PubMed Web of Science ®Google Scholar
• Mccullough JM, Fowle N, Sylvester T, et al. Cost analysis of 3 concurrent public health response events: financial impact of measles outbreak, super bowl surveillance, and ebola surveillance in maricopa county. J Public Health Manag Pract. 2019;25(4):357–365. doi:10.1097/PHH.0000000000000818.
   PubMed Web of Science ®Google Scholar
• Morgan DJ, Braun B, Milstone AM, et al. Lessons learned from hospital ebola preparation. Infect Control Hosp Epidemiol. 2015;36(6):627–631. doi:10.1017/ice.2015.61.
   PubMed Web of Science ®Google Scholar
• Ripper J, Nagurka R, Patel M, et al. 98 The cost of safety: implementation, maintenance, and patient care expenses of an emergency department ebola extended treatment area. Annals of Emergency Medicine. 2015;66(4):S34–S35. doi:10.1016/j.annemergmed.2015.07.130.
   Google Scholar
• Simonsen KA, Phipps AR, Hall M, et al. Costs associated with ebola preparedness at a freestanding pediatric assessment center. Infect Control Hosp Epidemiol. 2017;38(11):1367–1369. doi:10.1017/ice.2017.193.
   PubMed Web of Science ®Google Scholar
• Smit MA, Rasinski KA, Braun BI, et al. Ebola preparedness resources for acute-care hospitals in the United States: a cross-sectional study of costs, benefits, and challenges. Infect Control Hosp Epidemiol. 2017;38(4):405–410. doi:10.1017/ice.2017.6.
   PubMed Web of Science ®Google Scholar
• Suijkerbuijk AWM, Swaan CM, Mangen MJJ, et al. Ebola in The Netherlands, 2014–2015: costs of preparedness and response. Eur J Health Econ. 2018;19(7):935–943. doi:10.1007/s10198-017-0940-4.
   PubMed Web of Science ®Google Scholar
• Tariq H, Emes DT, Boo YY, et al. Economic impact of ebola virus disease outbreak on an extractive firm: a case study. UCL Open Environ. 2020;2:e007. doi:10.14324/111.444/ucloe.000007.
   PubMedGoogle Scholar
• Yacisin K, Balter S, Fine A, et al. Ebola virus disease in a humanitarian aid worker—New York city, october 2014. Mortality Weekly Report. 2015;64:321–323.
   PubMed Web of Science ®Google Scholar
• Boddie C. Federal funding in support of ebola medical countermeasures R&D. Health Secur. 2015;13(1):3–8. doi:10.1089/hs.2015.0001.
   PubMed Web of Science ®Google Scholar
• Fitchett JRA, Lichtman A, Soyode DT, et al. Ebola research funding: a systematic analysis, 1997-2015. J Glob Health. 2016;6(2):020703. doi:10.7189/jogh.06.020703.
   PubMed Web of Science ®Google Scholar
• Shimizu K, Checchi F, Warsame A. Disparities in health financing allocation among infectious diseases in ebola virus disease (EVD)-affected countries, 2005–2017. Healthcare (Switzerland). 2022;10(2):179. doi:10.3390/healthcare10020179.
   PubMedGoogle Scholar
• World Bank Group. World Bank Mobilizes US$300 Million to Finance the Ebola Response in Democratic Republic of Congo. World Bank Fiscal Report. 2019 cited 2020 Jul 6]. https://www.worldbank.org/en/news/press-release/2019/07/24/world-bank-mobilizes-us300-million-to-finance-the-ebola-response-in-democratic-republic-of-congo.
   Google Scholar
• Gavi. The Vaccine Alliance. Gavi boosts funding for Ebola outbreak response. https://www.gavi.org/news/media-room/gavi-boosts-funding-ebola-outbreakresponse.
   Google Scholar
• Office of the United Nations Special Envoy on Ebola. Resources for Results V. 2015. https://ebolaresponse.un.org/sites/default/files/resources_for_results_v.pdf.
   Google Scholar
• World Bank. 2014-2015 West africa ebola crisis: impact update. World Bank Fiscal Report. 2016.
   Google Scholar
• World Health Organization. Funding. 2020. https://www.who.int/emergencies/diseases/ebola/drc-2019/funding
   Google Scholar
• Mauskopf J, Standaert B, Connolly MP, et al. Economic analysis of vaccination programs: an ISPOR good practices for outcomes research task force report. Value in Health. 2018;21(10):1133–1149. https://www.valueinhealthjournal.com/article/S1098-3015(18)33267-4/fulltext?_returnURL=https%3A//linkinghub.elsevier.com/retrieve/pii/S1098301518332674%3Fshowall%3Dtrue. doi:10.1016/j.jval.2018.08.005.
   PubMed Web of Science ®Google Scholar
• WHO Guide on Standardization of Economic Evaluations of Immunization Programmes. 2023. https://www.who.int/publications-detail-redirect/WHO-IVB-19.10
   Google Scholar
• Clark DV, Kibuuka H, Millard M, et al. Long-term sequelae after ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. Lancet Infect Dis. 2015;15(8):905–912. doi:10.1016/S1473-3099(15)70152-0.
   PubMed Web of Science ®Google Scholar
• Mohammed H, Vandy AO, Stretch R, et al. Sequelae and other conditions in ebola virus disease survivors, Sierra Leone, 2015. Emerg Infect Dis. 2017;23(1):66–73. doi:10.3201/eid2301.160631.
   PubMed Web of Science ®Google Scholar
• Varkey JB, Shantha JG, Crozier I, et al. Persistence of ebola virus in ocular fluid during convalescence. N Engl J Med. 2015;372(25):2423–2427. doi:10.1056/NEJMoa1500306.
   PubMed Web of Science ®Google Scholar
• Smith J, Lipsitch M, Almond JW. Vaccine production, distribution, access, and uptake. Lancet. 2011;378(9789):428–438. doi:10.1016/S0140-6736(11)60478-9.
   PubMed Web of Science ®Google Scholar
• Hardt K, Bonanni P, King S, et al. Vaccine strategies: optimising outcomes. Vaccine. 2016;34(52):6691–6699. doi:10.1016/j.vaccine.2016.10.078.
   PubMed Web of Science ®Google Scholar
• Jit M, Hutubessy R. Methodological challenges to economic evaluations of vaccines: is a common approach still possible? Appl Health Econ Health Policy. 2016;14(3):245–252. doi:10.1007/s40258-016-0224-7.
   PubMed Web of Science ®Google Scholar
• Walker DG, Hutubessy R, Beutels P. WHO guide for standardisation of economic evaluations of immunization programmes. Vaccine. 2010;28(11):2356–2359. https://www.sciencedirect.com/science/article/pii/S0264410X09008986.
   PubMed Web of Science ®Google Scholar
• Pitt C, Vassall A, Teerawattananon Y, et al. Foreword: health economic evaluations in low- and Middle-income countries: methodological issues and challenges for priority setting. Health Econ. 2016;25(Suppl 1):1–5. doi:10.1002/hec.3319.
   PubMedGoogle Scholar
• Griffiths UK, Legood R, Pitt C. Comparison of cconomic evaluation methods across low-income, Middle-income and high-income countries: what are the differences and why? Health Econ. 2016;25 (Suppl 1):29–41. doi:10.1002/hec.3312.
   PubMed Web of Science ®Google Scholar